SCOTTSDALE, Ariz., Aug. 5, 2010 (GLOBE NEWSWIRE) -- NightHawk Radiology Holdings, Inc. (Nasdaq:NHWK), the leading provider of radiology solutions to radiology groups across the United States today announced its financial results for second quarter 2010.
Settlement with St. Paul Radiology, P.A. and Related Change in Reporting Basis
As previously announced, on June 30, 2010, the company completed its settlement transaction with St. Paul Radiology P.A. ("SPRPA"). As part of that settlement the company sold certain of its operations to a third party. Accordingly, these operations are classified as "discontinued operations" in the company's financial statements. This presentation, as required under GAAP, reports the revenue and expenses of the discontinued operations "net" in one line item as "net income (loss) from discontinued operations" on the company's statement of operations.
Highlights for the Second Quarter – Combined Operations
- Combined revenue was $38.8 million during the quarter, above the company's guidance range of $37.5 million to $38.5 million.
- GAAP net loss was $4.2 million, or 18 cents per share.
- Adjusted net income was $2.5 million, or 10 cents per diluted share, above the company's guidance range of 6 to 7 cents per diluted share. A reconciliation of adjusted net income to GAAP net loss is included in the tables attached to this press release.
- Cash flow from operations was $8.0 million.
- During the quarter we repaid $26.2 million on our term loan, reducing the remaining debt to $51.8 million.
- Cash and cash equivalents at June 30, 2010 totaled $24.3 million.
Highlights for the Second Quarter – Continuing Operations
- Revenue from continuing operations was $33.6 million for the quarter.
- Total scan volume increased 1% from the year ago quarter to 800,000 scans.
- Final scan volumes increased 37% from the year ago quarter, while preliminary scan volumes decreased 3% from the year ago quarter.
- GAAP net loss from continuing operations was $2.6 million, or 11 cents per share.
- Adjusted net income from continuing operations was $1.6 million, or 7 cents per diluted share. A reconciliation of adjusted net income to GAAP net loss is included in the tables attached to this press release.
Highlights of the Settlement with SPRPA
- The settlement with SPRPA is expected to result in payments to the Company totaling $26 million.
- At closing we received $12 million, consisting of $2.5 million in operating cash inflows and $9.5 million in cash flows from investing activities.
- The company also recorded a note receivable from SPRPA with a principal amount of $14 million. Under the terms of the note, SPRPA is obligated to pay the Company 48 monthly payments of $250,000 starting in August 2010 and a one-time payment of $2 million on or before March 31, 2011.
- The Company also recorded an income tax receivable of approximately $10 million related to the settlement, which we expect to receive during 2011.
Management Commentary
"We are pleased to report that our total revenue and adjusted EPS were above our guidance range as demand for our services remained solid and as we began to see benefits from our cost reduction efforts," said David Engert, the company's president and chief executive officer. "Looking ahead, we are focused on new opportunities to service and collaborate with our customers to help them meet their evolving needs in today's complex marketplace."
Third Quarter 2010 Outlook
The company estimates revenue for the third quarter of 2010 to be in the range of $32 to $33 million and adjusted EPS to be in the range of 6 to 8 cents.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the company's outlook on its revenue and adjusted earnings per share for future periods, the expected cash payments to be received from SPRPA under the terms of the settlement, the expected future tax refunds arising from the settlement, and the opportunity to collaborate with our customers to meet the evolving needs of the marketplace. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made, general economic conditions, competitive conditions in the radiology industry, and regulatory risks. Other factors that could cause operating and financial results to differ are described in the company's periodic reports filed with the Securities and Exchange Commission ("SEC"). Other risks may be detailed from time to time in reports to be filed with the SEC. NightHawk does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.
Earnings Conference Call
The second quarter conference call will be held today, August 5, 2010 at 4:30 p.m. eastern time. A live webcast of the conference call, as well as a replay, will be available online on the company's corporate website at http://www.nighthawkrad.net. Participants can also access the call by dialing (877) 941-2332 or (480) 629-9692 (for local or international callers). A replay of the call will be available approximately two hours after the conclusion of the call and will remain available until midnight eastern time on Thursday, September 2, 2010. To access the replay, dial (800)406-7325 or (303)590-3030 (for international callers) and enter the conference ID number: 4329508
About NightHawk
NightHawk Radiology (Nasdaq:NHWK), headquartered in Scottsdale, Arizona, is the nation's leading provider of professional radiology solutions. NightHawk is leading the transformation of the professional practice of radiology by providing high-quality, cost-effective radiology services to radiology groups and hospitals throughout the United States. NightHawk's suite of solutions, including its advanced, proprietary workflow technology, is reshaping the way radiology groups practice by increasing efficiencies and improving the quality of patient care. With its team of U.S. board certified, state-licensed and hospital-privileged physicians, NightHawk services medical groups twenty-four hours a day, seven days a week at approximately 1,600 hospitals in the U.S. from centralized facilities located in the United States, Australia and Switzerland. For more information, visit http://www.nighthawkrad.net.
The NightHawk Radiology Services logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=5531
Presentation of Non-GAAP Financial Information
The presentation of adjusted revenue including discontinued operations, adjusted net income and adjusted earnings per diluted share are not measures of financial performance under GAAP and should not be considered a substitute for or superior to GAAP. Management believes these non-GAAP financial measures provide useful information to both management and investors by excluding certain expenses that may not be indicative of our core results and provide consistency in financial reporting. Specifically, the company's non-GAAP adjusted revenue including discontinued operations described in this release includes the sum of revenues from continuing operations and revenues from discontinued operations. In addition, the company's non-GAAP adjusted net income measure, and related adjusted earnings per diluted share, described in this release exclude the tax effected impact of (i) the non-cash expense related to our stock-based compensation, (ii) the non-cash expense associated with the amortization of intangibles associated with acquisitions, (iii) the non-cash expenses (or credits) for adjustments to our IBNR reserve (incurred but not reported medical liability reserves), (iv) non-cash interest expense, (v) restructuring costs, (vi) the non-cash charges for goodwill or intangible asset impairments, (vii) non-cash adjustments for deferred tax balances and (viii) other one-time or non-cash expenses accounted for from time to time. These other expenses may occur in future periods, but the amounts recognized can vary from period to period and do not directly relate to the ongoing operations of the Company.
We exclude the non-cash charges related to our stock-based compensation due to the varying valuation methodologies, subjective assumptions and the variety of types of awards that companies can use when applying The Compensation Topic of the FASB Accounting Standards Codification (Topic 718) along with the fact that a substantial portion of our restricted stock units are held by our independent contractor physicians and require accounting treatment that differs from the accounting treatment for other stock-based awards held by employees.
The company provides non-GAAP adjusted net income and related adjusted earnings per diluted share as financial measures because management believes these measures provide greater transparency with respect to information used by management in its financial and operational decision making and to enhance investors' overall understanding of our current financial performance and our future prospects. For reconciliation of our non-GAAP financial measures to the most applicable GAAP financial measure, please refer to the information included in the attached tables of this press release and in the Investor Relations section of our corporate website.
"NHWKF"
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||
| CONSOLIDATED BALANCE SHEETS (unaudited) | ||
| ASSETS | June 30, 2010 | December 31, 2009 |
| (in thousands, except share data) | ||
| Current assets: | ||
| Cash and cash equivalents | $ 24,311 | $ 26,293 |
| Marketable securities | -- | 6,000 |
| Trade accounts receivable, net | 17,393 | 17,468 |
| Notes receivable, current | 4,609 | -- |
| Deferred income taxes | 2,426 | 1,022 |
| Income tax receivable | 11,626 | 2,215 |
| Prepaid expenses and other current assets | 3,357 | 1,922 |
| Current assets of discontinued operations | 1,492 | 4,344 |
| Total current assets | 65,214 | 59,264 |
| Property and equipment, net | 10,368 | 11,025 |
| Intangible assets, net | 20,287 | 22,190 |
| Deferred income taxes | 13,962 | 14,408 |
| Notes receivable, non-current | 8,173 | -- |
| Other assets, net | 2,069 | 4,646 |
| Long-term assets of discontinued operations | -- | 54,141 |
| Total | $ 120,073 | $ 165,674 |
| LIABILITIES | ||
| Current liabilities: | ||
| Accounts payable | $ 6,166 | $ 6,130 |
| Accrued expenses and other liabilities | 3,506 | 3,160 |
| Accrued payroll and related benefits | 3,535 | 3,460 |
| Long-term debt, due within one year | 10,518 | 802 |
| Current liabilities of discontinued operations | 266 | 622 |
| Total current liabilities | 23,991 | 14,174 |
| Insurance reserve | 3,127 | 4,018 |
| Long-term debt | 41,287 | 77,404 |
| Other liabilities | 4,635 | 1,348 |
| Total liabilities | 73,040 | 96,944 |
| STOCKHOLDERS' EQUITY | ||
| Common stock-150,000,000 shares authorized; $.001 par value; 23,717,467 and 23,558,890 shares issued and outstanding, respectively | 24 | 24 |
| Additional paid-in capital | 222,247 | 221,106 |
| Retained earnings (deficit) | (175,039) | (151,660) |
| Accumulated other comprehensive income (deficit) | (199) | (740) |
| Total stockholders' equity | 47,033 | 68,730 |
| Total | $ 120,073 | $ 165,674 |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||||
| CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) | ||||
| Three months ended June 30, | Six months ended June 30, | |||
| 2010 | 2009 | 2010 | 2009 | |
| (in thousands, except per share data) | (in thousands, except per share data) | |||
| Service revenue | $ 33,560 | $ 36,760 | $ 65,165 | $ 70,342 |
| Operating costs and expenses: | ||||
| Professional services | 16,327 | 17,393 | 32,986 | 33,261 |
| Sales, general, and administrative | 13,538 | 13,211 | 26,666 | 25,224 |
| Depreciation and amortization | 1,894 | 1,833 | 3,779 | 3,749 |
| Goodwill and intangible asset impairment | -- | -- | -- | 61,785 |
| Total operating costs and expenses | 31,759 | 32,437 | 63,431 | 124,019 |
| Operating income (loss) | 1,801 | 4,323 | 1,734 | (53,677) |
| Other income (expense): | ||||
| Interest expense | (3,744) | (1,630) | (6,828) | (3,628) |
| Interest income | 20 | 50 | 72 | 105 |
| Other, net | 21 | (16) | 31 | (8) |
| Total other income (expense) | (3,703) | (1,596) | (6,725) | (3,531) |
| Income (loss) from continuing operations before income taxes | (1,902) | 2,727 | (4,991) | (57,208) |
| Income tax expense (benefit) | 664 | 1,065 | 25 | (10,186) |
| Net income (loss) from continuing operations | (2,566) | 1,662 | (5,016) | (47,022) |
| Net income (loss) from discontinued operations | (1,619) | 432 | (18,364) | (3,497) |
| Net income (loss) | $ (4,185) | $ 2,094 | $ (23,380) | $ (50,519) |
| Basic earnings (loss) per common share: | ||||
| Basic net income (loss) per share from continuing operations | $ (0.11) | $ 0.06 | $ (0.21) | $ (1.77) |
| Basic net income (loss) per share from discontinued operations | $ (0.07) | $ 0.02 | $ (0.78) | $ (0.13) |
| Basic net income (loss) per common share | $ (0.18) | $ 0.08 | $ (0.99) | $ (1.90) |
| Diluted earnings (loss) per common share: | ||||
| Diluted net income (loss) per share from continuing operations | $ (0.11) | $ 0.06 | $ (0.21) | $ (1.77) |
| Diluted net income (loss) per share from discontinued operations | $ (0.07) | $ 0.02 | $ (0.78) | $ (0.13) |
| Diluted net income (loss) per common share | $ (0.18) | $ 0.08 | $ (0.99) | $ (1.90) |
| Weighted averages of common shares outstanding: | ||||
| Basic | 23,671,256 | 26,490,880 | 23,624,158 | 26,569,576 |
| Diluted | 23,671,256 | 26,958,693 | 23,624,158 | 26,569,576 |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | ||
| CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) | ||
| Six months ended June 30, | ||
| 2010 | 2009 | |
| (in thousands) | ||
| Cash flows from operating activities: | ||
| Net income (loss) | $ (23,380) | $ (50,519) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 6,920 | 5,513 |
| Goodwill and intangible asset impairment | 27,326 | 68,718 |
| Amortization of debt issuance costs and effect of interest rate swaps | 6,272 | 2,114 |
| Deferred income taxes | (110) | (14,195) |
| Non-cash stock compensation expense | 1,207 | 2,594 |
| Other, net | 61 | 636 |
| Changes in operating assets and liabilities: | ||
| Trade accounts receivable, net | (154) | 844 |
| Trade accounts receivable related to SPRPA settlement | 2,500 | -- |
| Prepaid expenses and other assets | (1,170) | (1,899) |
| Income tax receivable | (9,410) | 947 |
| Accounts payable | 238 | 389 |
| Accrued expenses and other liabilities | 95 | (959) |
| Accrued payroll and related benefits | 356 | 294 |
| Net cash provided by operating activities | 10,751 | 14,477 |
| Cash flows from investing activities: | ||
| Purchase of marketable securities | -- | (4,990) |
| Proceeds from maturities of marketable securities | 6,000 | -- |
| Purchase of property and equipment | (1,769) | (2,156) |
| Termination fee received related to SPRPA settlement | 7,500 | -- |
| Proceeds from sale of business | 2,000 | -- |
| Net cash provided by (used in) investing activities | 13,731 | (7,146) |
| Cash flows from financing activities: | . | |
| Repayment of debt | (26,401) | (478) |
| Proceeds from exercise of stock options | 55 | 50 |
| Withholding taxes paid related to restricted stock net settlement | (121) | -- |
| Excess tax benefit from exercise of stock options | 3 | 8 |
| Purchase and retirement of common stock | -- | (6,452) |
| Debt amendment costs | -- | (434) |
| Cash exchange for stock options | -- | (53) |
| Net cash used in financing activities | (26,464) | (7,359) |
| Net increase (decrease) in cash and cash equivalents | (1,982) | (28) |
| Cash and cash equivalents—beginning of period | 26,293 | 47,160 |
| Cash and cash equivalents—end of period | $ 24,311 | $ 47,132 |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | |||||||
| NON-GAAP RECONCILIATIONS | |||||||
| (in thousands) | |||||||
| Reconciliation of Revenue to Adjusted Revenue including Discontinued Operations | |||||||
| Three Months Ended | Six Months Ended | ||||||
| June 30, 2010 | June 30, 2009 | June 30, 2010 | June 30, 2009 | ||||
| Revenue from Continuing Operations | $ 33,560 | $ 36,760 | $ 65,165 | $ 70,342 | |||
| Addback impact of: | |||||||
| Revenue from Discontinued Operations | 5,269 | 5,580 | 10,212 | 10,797 | |||
| Adjusted Revenue Including Discontinued Operations | $ 38,829 | $ 42,340 | $ 75,377 | $ 81,139 | |||
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | |||||
| HISTORICAL VOLUMES | |||||
| Total Volumes (Including Volumes from Discontinued Operations) | |||||
| Growth Rates | |||||
| Quarter | Year | Total Volumes | Sequential | Year over Year | |
| FY | 2008 | 3,035,095 | |||
| Q1 | 2009 | 722,321 | |||
| Q2 | 2009 | 817,315 | 13% | 5% | |
| Q3 | 2009 | 864,898 | 6% | 9% | |
| Q4 | 2009 | 769,789 | (11%) | 7% | |
| FY | 2009 | 3,174,323 | 5% | 5% | |
| Q1 | 2010 | 765,151 | (1%) | 6% | |
| Q2 | 2010 | 826,904 | 8% | 1% | |
| Volumes from Continuing Operations | |||||
| Growth Rates | |||||
| Quarter | Year | Total Volumes | Sequential | Year over Year | |
| FY | 2008 | 2,950,829 | |||
| Q1 | 2009 | 701,316 | |||
| Q2 | 2009 | 792,313 | 13% | ||
| Q3 | 2009 | 841,031 | 6% | ||
| Q4 | 2009 | 748,408 | (11%) | ||
| FY | 2009 | 3,083,068 | 4% | 4% | |
| Q1 | 2010 | 742,432 | (1%) | 6% | |
| Q2 | 2010 | 800,493 | 8% | 1% | |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | |||||||
| NON-GAAP RECONCILIATIONS | |||||||
| (in thousands, except share data) | |||||||
| Reconciliation of Net Income (Loss) to Adjusted Net Income | |||||||
| Three Months Ended | Six Months Ended | ||||||
| June 30, 2010 | June 30, 2009 | June 30, 2010 | June 30, 2009 | ||||
| Net income (loss) | $ (4,185) | $ 2,094 | $ (23,380) | $ (50,519) | |||
| Tax effected impact of: | |||||||
| Non-cash stock based compensation | 2,522 | 946 | 3,390 | 1,589 | |||
| Amortization of intangible assets | 1,774 | 1,059 | 2,824 | 2,212 | |||
| IBNR medical malpractice loss reserves | (533) | -- | (533) | 242 | |||
| Non-cash interest expense | 2,295 | 337 | 3,581 | 883 | |||
| Goodwill and intangible asset impairment | -- | -- | 16,927 | 54,029 | |||
| Restructuring costs | 632 | -- | 902 | -- | |||
| Non-cash adjustment to deferred tax balances | (50) | -- | (50) | -- | |||
| Adjusted net income | $ 2,455 | $ 4,436 | $ 3,661 | $ 8,436 | |||
| Reconciliation of Diluted Earnings (Loss) per share to Adjusted Diluted Earnings per Share | |||||||
| Three Months Ended | Six Months Ended | ||||||
| June 30, 2010 | June 30, 2009 | June 30, 2010 | June 30, 2009 | ||||
| Diluted earnings (loss) per share | $ (0.18) | $ 0.08 | $ (0.99) | $ (1.90) | |||
| Tax effected impact of: | |||||||
| Non-cash stock based compensation | 0.11 | 0.03 | 0.14 | 0.06 | |||
| Amortization of intangible assets | 0.07 | 0.04 | 0.12 | 0.08 | |||
| IBNR medical malpractice loss reserves | (0.02) | -- | (0.02) | 0.01 | |||
| Non-cash interest expense | 0.09 | 0.01 | 0.15 | 0.03 | |||
| Goodwill and intangible asset impairment | -- | -- | 0.71 | 2.03 | |||
| Restructuring costs | 0.03 | -- | 0.04 | -- | |||
| Non-cash adjustment to deferred tax balances | -- | -- | -- | -- | |||
| Adjusted diluted earnings per share | $ 0.10 | $ 0.16 | $ 0.15 | $ 0.31 | |||
| Weighted average basic shares outstanding | 23,671,256 | 26,490,880 | 23,624,158 | 26,569,576 | |||
| Weighted average diluted shares outstanding, adjusted | 24,405,921 | 26,958,693 | 24,255,902 | 26,929,172 | |||
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | |||||
| NON-GAAP RECONCILIATIONS | |||||
| (in thousands, except share data) | |||||
| Reconciliation of Net Income (Loss) from Continuing Operations to Adjusted Net Income from Continuing Operations | |||||
| Three Months Ended | Six Months Ended | ||||
| June 30, 2010 | June 30, 2009 | June 30, 2010 | June 30, 2009 | ||
| Net income (loss) from Continuing Operations | $ (2,566) | $ 1,662 | $ (5,016) | $ (47,022) | |
| Tax effected impact of: | |||||
| Non-cash stock based compensation | 2,181 | 946 | 3,049 | 1,589 | |
| Amortization of intangible assets | 565 | 611 | 1,159 | 1,310 | |
| IBNR medical malpractice loss reserves | (533) | -- | (533) | 242 | |
| Non-cash interest expense | 1,660 | 337 | 2,946 | 883 | |
| Goodwill and intangible asset impairment | -- | -- | -- | 49,755 | |
| Restructuring costs | 632 | -- | 902 | -- | |
| Non-cash adjustment to deferred tax balances | (336) | -- | (336) | -- | |
| Adjusted net income from Continuing Operations | $ 1,603 | $ 3,556 | $ 2,171 | $ 6,757 | |
| Reconciliation of Diluted Earnings (Loss) per share from Continuing Operations to Adjusted Diluted Earnings per Share from Continuing Operations | |||||
| Three Months Ended | Six Months Ended | ||||
| June 30, 2010 | June 30, 2009 | June 30, 2010 | June 30, 2009 | ||
| Diluted earnings (loss) per share | $ (0.11) | $ 0.06 | $ (0.21) | $ (1.77) | |
| Tax effected impact of: | |||||
| Non-cash stock based compensation | 0.09 | 0.04 | 0.12 | 0.06 | |
| Amortization of intangible assets | 0.02 | 0.02 | 0.05 | 0.05 | |
| IBNR medical malpractice loss reserves | (0.02) | -- | (0.02) | 0.01 | |
| Non-cash interest expense | 0.07 | 0.01 | 0.12 | 0.03 | |
| Goodwill and intangible asset impairment | -- | -- | -- | 1.87 | |
| Restructuring costs | 0.03 | -- | 0.04 | -- | |
| Non-cash adjustment to deferred tax balances | (0.01) | -- | (0.01) | -- | |
| Adjusted diluted earnings per share | $ 0.07 | $ 0.13 | $ 0.09 | $ 0.25 | |
| Weighted average basic shares outstanding | 23,671,256 | 26,490,880 | 23,624,158 | 26,569,576 | |
| Weighted average diluted shares outstanding, adjusted | 24,405,921 | 26,958,693 | 24,255,902 | 26,929,172 | |
| NIGHTHAWK RADIOLOGY HOLDINGS, INC. AND SUBSIDIARIES | |||||||
| NON-GAAP RECONCILIATIONS | |||||||
| (in thousands, except share data) | |||||||
| Reconciliation of Net Income (Loss) from Discontinued Operations to Adjusted Net Income from Discontinued Operations | |||||||
| Three Months Ended | Six Months Ended | ||||||
| June 30, 2010 | June 30, 2009 | June 30, 2010 | June 30, 2009 | ||||
| Net income (loss) from Discontinued Operations | $ (1,619) | $ 432 | $ (18,364) | $ (3,497) | |||
| Tax effected impact of: | |||||||
| Non-cash stock based compensation | 341 | -- | 341 | -- | |||
| Amortization of intangible assets | 1,209 | 448 | 1,665 | 902 | |||
| IBNR medical malpractice loss reserves | -- | -- | -- | -- | |||
| Non-cash interest expense | 635 | -- | 635 | -- | |||
| Goodwill and intangible asset impairment | -- | -- | 16,927 | 4,274 | |||
| Restructuring costs | -- | -- | -- | -- | |||
| Non-cash adjustment to deferred tax balances | 286 | -- | 286 | -- | |||
| Adjusted net income from Discontinued Operations | $ 852 | $ 880 | $ 1,490 | $ 1,679 | |||
| Reconciliation of Diluted Earnings (Loss) per share from Discontinued Operations to Adjusted Diluted Earnings per Share from Discontinued Operations | |||||||
| Three Months Ended | Six Months Ended | ||||||
| June 30, 2010 | June 30, 2009 | June 30, 2010 | June 30, 2009 | ||||
| Diluted earnings (loss) per share on Discontinued Operations | $ (0.07) | $ 0.02 | $ (0.78) | $ (0.13) | |||
| Tax effected impact of: | |||||||
| Non-cash stock based compensation | 0.01 | -- | 0.01 | -- | |||
| Amortization of intangible assets | 0.05 | 0.01 | 0.07 | 0.03 | |||
| IBNR medical malpractice loss reserves | -- | -- | -- | -- | |||
| Non-cash interest expense | 0.03 | -- | 0.03 | -- | |||
| Goodwill and intangible asset impairment | -- | -- | 0.72 | 0.16 | |||
| Restructuring costs | -- | -- | -- | -- | |||
| Non-cash adjustment to deferred tax balances | 0.01 | -- | 0.01 | -- | |||
| Adjusted diluted earnings per share on Discontinued Operations | $ 0.03 | $ 0.03 | $ 0.06 | $ 0.06 | |||
| Weighted average basic shares outstanding | 23,671,256 | 26,490,880 | 23,624,158 | 26,569,576 | |||
| Weighted average diluted shares outstanding, adjusted | 24,405,921 | 26,958,693 | 24,255,902 | 26,929,172 | |||